Morocco’s Ministry of Health decided to supply health facilities across the country with chloroquine and its derivative, hydroxychloroquine, whose tests on patients infected with the coronavirus proved encouraging. The decision was made after consultations with the technical and scientific committee of the national program for the prevention and control of influenza and acute respiratory infections, the Health Ministry said in a press release. The health department, which has made efforts to ensure the medication’s availability, urges that chloroquine stocks must be managed by the heads of regional supply and pandemic units at the level of regional health directorates. According to press reports, the Moroccan authorities bought all the stock of Nivaquine, produced in by the Sanofi laboratories in its factories in Casablanca. Morocco also placed an order for an additional quantity of Nivaquine from Sanofi laboratories.

Source: The North Africa Journal March 24, 2020 12:45 UTC